Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
(111)In-DTPA-anti-γH2AX-Tat, which combines an anti-γH2AX antibody with a cell-penetrating peptide, Tat, and the Auger electron-emitting radioisotope, (111)In, targets the DNA damage signalling protein, γH2AX, and has potential as a probe for imaging DNA damage in vivo. The goal of this study was to...
Príomhchruthaitheoirí: | Cornelissen, B, Darbar, S, Kersemans, V, Allen, D, Falzone, N, Barbeau, J, Smart, S, Vallis, K |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2012
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2012) -
Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2011) -
PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
de réir: Knight, J, et al.
Foilsithe / Cruthaithe: (2015) -
PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
de réir: Knight, J, et al.
Foilsithe / Cruthaithe: (2015) -
Molecular radiotherapy using cleavable radioimmunoconjugates that target eGFR and γH2AX
de réir: Cornelissen, B, et al.
Foilsithe / Cruthaithe: (2013)